This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Murphy, D. A. Articles by Farthing, C. Search for Related Content PubMed PubMed Citation Articles by Murphy, D. A. Articles by Farthing, C. Social Bookmarking                         What's this?

Results of an Antiretroviral Adherence Intervention: STAR (Staying Healthy: Taking Antiretrovirals Regularly)

Health Risk Reduction Projects, Integrated Substance Abuse Programs, Department of Psychiatry, University of California, Los Angeles, dmurphy{at}mednet.ucla.edu

William D. Marelich, PhD

Department of Psychology, California State University, Fullerton

Neil B. Rappaport, PhD

Medical Psychology Associates, Atlanta GA

Dannie Hoffman, MA

Health Risk Reduction Projects, Integrated Substance Abuse Programs, Department of Psychiatry, University of California, Los Angeles

Charles Farthing, MD

AIDS Healthcare Foundation, Los Angeles CA

A randomized 2-group medication adherence intervention is evaluated with HIV-infected adults (N = 141) assessed at baseline, 3-, and 9-month follow-ups. Cognitive (self-efficacy, behavioral intent), mental health (depression, well-being), and substance use indicators were the outcome measures. In addition, a posttest-only analysis from 3 to 9 months evaluates intervention impact on antiretroviral adherence, measured through Medication Event Monitoring System and pill counts. Compared to the standard care group, the intervention group showed significant increases in adherence self-efficacy and behavioral intent at 3 and 9 months and marginal improvements in mental health. Although the standard care group had higher adherence at 3 months (no baseline data were available prior to intervention), intervention group patients showed significant increases in adherence from 3 to 9 months. Although adherence levels achieved by intervention patients may not be sufficient for virological control, this is one of the first studies to provide promising results of longer term effectiveness of a behavioral adherence intervention.

Key Words: experimental design • sampling (experimental) • human immunodeficiency virus • maintenance therapy • drug therapy

Journal of the International Association of Physicians in AIDS Care (JIAPAC), Vol. 6, No. 2, 113-124 (2007)
DOI: 10.1177/1545109707301243


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?